For blood treatment in Singapore, we partner with 4 hospitals: Farrer Park Hospital, Gleneagles Hospital, Mount Elizabeth Hospital and other hospitals. 1 of them is JCI-accredited. The right hospital depends on your case. Our doctors read your test results, then recommend the hospital.
4 partner hospitals in Singapore
16 haematology specialists in Singapore
1.5 hours Jakarta to Singapore, direct
30 days visa-free, Indonesian passport
1 of 4 partner hospitals here are JCI-accredited
Dr. Ratu Lucky · Dr. Nabilla Risdiana
Associate Medical Director
Ask our doctors about blood treatment in Singapore
A doctor reads every message
Free for you, paid by partner hospitals
You pay the hospital's price, no markup
Free. Our doctors reply on WhatsApp.
Partner hospitals
Our partner hospitals for blood treatment in Singapore
Sorted by city and name, not ranked. Our doctors help you choose for your case.
Modern integrated healthcare facility combining hospital and specialist medical services in a smart hospital-hotel environment, offering personalised care, advanced technology, and holistic treatment.
221-bed private hospital in Singapore that houses a comprehensive range of specialist, diagnostic and imaging services. At Gleneagles, we're On Your Side.
Dr Colin Phipps is a haematologist practising at Mount Elizabeth Hospitals and Gleneagles Hospital, Singapore.
He specialises in lymphoma and blood cancers, and haematopoietic stem cell transplantation.
Dr Phipps received his medical degree from the National University of Ireland in 2002 and subsequently completed internal medicine residency and specialist training in haematology at Singapore General Hospital (SGH).
He was awarded the HMDP fellowship to pursue subspecialty training in lymphoma and bone marrow transplantation at the renowned Fred Hutchinson Cancer Research Centre in Seattle.
Dr Phipps spent 10 years with the department of haematology at SGH. There, he was appointed as lymphoma director in 2012 and helped build the lymphoma programme, later becoming the lymphoma lead for the SingHealth-DUKE Blood Cancer Centre, which brought together lymphoma teams from SGH and National Cancer Centre Singapore.
He has overseen the management of hundreds of patients with complex blood cancers, including resistant lymphomas and those undergoing transplantation. He also headed numerous pharmaceutical-sponsored and investigator-initiated clinical trials that have allowed patients access to many novel treatments.
Dr Phipps is actively involved in undergraduate and postgraduate training of young doctors in Singapore. He has held roles including postgraduate mentor and senior lecturer with NUS Yong Loo Lin School of Medicine, as well as MBBS examiner and assistant adjunct professor with DUKE-NUS Medical School.
He has authored more than 30 papers in peer-reviewed journals, including Transplantation, Critical Reviews in Oncology-Haematology, and Bone Marrow Transplantation. His expertise in the field of lymphoma and bone marrow transplantation has led him to serve as advisor to numerous regional and international expert panels and education programmes.
Dr Colin Phipps is a haematologist practising at Mount Elizabeth Hospitals and Gleneagles Hospital, Singapore.
He specialises in lymphoma and blood cancers, and haematopoietic stem cell transplantation.
Dr Phipps received his medical degree from the National University of Ireland in 2002 and subsequently completed internal medicine residency and specialist training in haematology at Singapore General Hospital (SGH).
He was awarded the HMDP fellowship to pursue subspecialty training in lymphoma and bone marrow transplantation at the renowned Fred Hutchinson Cancer Research Centre in Seattle.
Dr Phipps spent 10 years with the department of haematology at SGH. There, he was appointed as lymphoma director in 2012 and helped build the lymphoma programme, later becoming the lymphoma lead for the SingHealth-DUKE Blood Cancer Centre, which brought together lymphoma teams from SGH and National Cancer Centre Singapore.
He has overseen the management of hundreds of patients with complex blood cancers, including resistant lymphomas and those undergoing transplantation. He also headed numerous pharmaceutical-sponsored and investigator-initiated clinical trials that have allowed patients access to many novel treatments.
Dr Phipps is actively involved in undergraduate and postgraduate training of young doctors in Singapore. He has held roles including postgraduate mentor and senior lecturer with NUS Yong Loo Lin School of Medicine, as well as MBBS examiner and assistant adjunct professor with DUKE-NUS Medical School.
He has authored more than 30 papers in peer-reviewed journals, including Transplantation, Critical Reviews in Oncology-Haematology, and Bone Marrow Transplantation. His expertise in the field of lymphoma and bone marrow transplantation has led him to serve as advisor to numerous regional and international expert panels and education programmes.
Dr Colin Phipps is a haematologist practising at Mount Elizabeth Hospitals and Gleneagles Hospital, Singapore.
He specialises in lymphoma and blood cancers, and haematopoietic stem cell transplantation.
Dr Phipps received his medical degree from the National University of Ireland in 2002 and subsequently completed internal medicine residency and specialist training in haematology at Singapore General Hospital (SGH).
He was awarded the HMDP fellowship to pursue subspecialty training in lymphoma and bone marrow transplantation at the renowned Fred Hutchinson Cancer Research Centre in Seattle.
Dr Phipps spent 10 years with the department of haematology at SGH. There, he was appointed as lymphoma director in 2012 and helped build the lymphoma programme, later becoming the lymphoma lead for the SingHealth-DUKE Blood Cancer Centre, which brought together lymphoma teams from SGH and National Cancer Centre Singapore.
He has overseen the management of hundreds of patients with complex blood cancers, including resistant lymphomas and those undergoing transplantation. He also headed numerous pharmaceutical-sponsored and investigator-initiated clinical trials that have allowed patients access to many novel treatments.
Dr Phipps is actively involved in undergraduate and postgraduate training of young doctors in Singapore. He has held roles including postgraduate mentor and senior lecturer with NUS Yong Loo Lin School of Medicine, as well as MBBS examiner and assistant adjunct professor with DUKE-NUS Medical School.
He has authored more than 30 papers in peer-reviewed journals, including Transplantation, Critical Reviews in Oncology-Haematology, and Bone Marrow Transplantation. His expertise in the field of lymphoma and bone marrow transplantation has led him to serve as advisor to numerous regional and international expert panels and education programmes.
Which hospitals in Singapore offer blood treatment?
For blood treatment in Singapore, we partner with 4 hospitals: Farrer Park Hospital, Gleneagles Hospital, Mount Elizabeth Hospital and other hospitals. Our doctors help you choose based on your case.
How long is the flight from Jakarta to Singapore?
About 1.5 hours on a direct flight.
Do Indonesian passport holders need a visa for Singapore?
No, for visits of up to 30 days. If your treatment takes longer, ask us before you travel.
Which documents should I bring?
Your latest test results, a summary of your medical records and your passport. Send them on WhatsApp first so our doctors can read them before you travel.
Does Medifly charge a fee?
No. Our service is paid by partner hospitals, and you pay the hospital's price with no markup.
The right hospital depends on your case. Our doctors help you choose.
Reviewed by Dr. Ratu Lucky Nitibaskara, Associate Medical Director, 23 Sept 2026. Data updated 23 Sept 2026. Sources: Medifly partner doctor and hospital data, direct flight schedules.